Peptides

ACE-031 is a research compound employed in preclinical experimental systems to study myostatin pathway modulation and its involvement in skeletal muscle biology and tissue remodeling.

Adenosine monophosphate (AMP) has a well-known experimental analog in the molecule AICAR. In preclinical research models, AICAR has been extensively used to investigate AMPK-mediated cellular energy regulation, metabolic stress responses, and redox balance. In in vitro systems and animal studies, AICAR has been evaluated in experimental contexts related to cardiac ischemia models, where AMPK activation has been associated with modulation of cellular survival pathways under ischemic stress. Due to its role in regulating oxidative stress and energy metabolism, AICAR has also been studied in experimental ageing-related models, as well as in preclinical models of metabolic and inflammatory dysregulation, including those used to investigate mechanisms relevant to insulin signaling, immune activation, and chronic inflammation. These findings are limited to controlled laboratory and animal research settings and are used to explore underlying biological mechanisms rather than clinical applications.

AOD9604 is a synthetic peptide derived from the C-terminal fragment (176–191) of human growth hormone (hGH), incorporating a disulfide bridge for structural stability. It is used in preclinical research models to investigate lipid metabolism, adipose tissue regulation, and related metabolic pathways, including experimental effects on lipolysis and lipogenesis. In animal and in vitro studies, AOD9604 has also been explored in research contexts involving metabolic, cardiometabolic, and musculoskeletal biology, including experimental models of bone and cartilage tissue remodeling, alone or in combination with other research peptides.  

ARA-290 has been investigated in preclinical and experimental research models designed to study inflammatory, metabolic, vascular, and neurobiological mechanisms relevant to the following disease-related research contexts: Cardiovascular-related experimental modelsRetinal ischemia and microvascular injury models Peripheral nerve injury and neuropathy models Small fiber nerve degeneration models Chronic inflammatory joint disease models Renal inflammation and metabolic stress models Hepatic lipid accumulation and inflammatory liver models Intestinal inflammation models Systemic autoimmune and immune dysregulation models Wound healing and tissue repair models 

ATN-161 is a synthetic pentapeptide used in preclinical research models to study integrin–extracellular matrix interactions, particularly those involving fibronectin binding. In in vitro systems and animal studies, modulation of these interactions has been employed to investigate cell adhesion, migration, angiogenesis-related signaling, and tissue remodeling mechanisms under experimental conditions.

B7-33 has been investigated in preclinical research models related to: Fibrotic tissue remodeling models Vascular protection and endothelial signaling models Cardiac injury and post-ischemic remodeling models Pulmonary inflammation and fibrosis-related models 

Summary Bonomarlot, also known as Myelopeptide-2 (MP-2), is a synthetic hexapeptide derived from bone marrow peptides and studied for its immunomodulatory properties in experimental settings. It has demonstrated the ability to restore T-lymphocyte proliferation and normalize key surface markers such as CD3 and CD4 under conditions of immune suppression induced by tumor-derived factors. These effects suggest a role in supporting cellular signaling pathways involved in T-cell activation and functional recovery. Due to its small size and hydrophobic composition, MP-2 may interact efficiently with cellular membranes and protein interfaces, contributing to its biological activity. Current data are limited to preclinical research models, where MP-2 is used as a tool to investigate immune regulation, cellular recovery mechanisms, and tumor-associated immunosuppression.

BPC-157 is a 15-amino-acid synthetic peptide used in preclinical research models to investigate cellular repair mechanisms, extracellular matrix dynamics, vascular signaling, and tissue stress responses. In in vitro systems and animal studies, BPC-157 has been explored for its involvement in pathways related to fibroblast activity, angiogenesis, nitric oxide-associated signaling, coagulation-related processes, immune modulation, and gene expression regulation under experimental conditions. Thymosin Beta-4 is a 43-amino-acid peptide widely used in preclinical experimental systems to study actin-mediated cell migration, angiogenesis, inflammatory signaling, and tissue remodeling processes. In laboratory and animal models, Thymosin Beta-4 has been investigated for its role in wound-associated cell dynamics, oxidative stress responses, and regeneration-related signaling pathways. 

BPC-157 is a 15-amino-acid synthetic peptide used in preclinical research models to investigate cellular repair mechanisms, extracellular matrix dynamics, vascular signaling, and tissue stress responses. In in vitro systems and animal studies, BPC-157 has been explored for its involvement in pathways related to fibroblast activity, angiogenesis, nitric oxide-associated signaling, coagulation-related processes, immune modulation, and gene expression regulation under experimental conditions.

cAC-253 is a disulfide-cyclized research peptide used in preclinical experimental models to investigate amylin receptor–mediated signaling under conditions of amyloid-associated cellular stress. In in vitro systems and animal studies, cAC-253 has been explored for its effects on synaptic function, learning- and memory-related signaling pathways, amyloid-associated biochemical markers, and neuroinflammatory responses, providing a tool for mechanistic research into receptor-specific pathways involved in synaptic integrity.

Cardiogen is a short synthetic peptide used in preclinical research models to study fibroblast-associated signaling and tissue remodeling mechanisms. In in vitro systems and animal studies, it has been investigated for its role in regulating cellular processes involved in extracellular matrix organization and scar-related responses under experimental conditions.

Chonluten has been explored in relation to the regulation of pulmonary mucosa, gene networks involved in inflammatory and antioxidant processes, and tissue adaptation mechanisms across a broad range of acute and chronic respiratory and systemic stress conditions, of both infectious and non-infectious origin, including age-associated functional decline. Experimental findings indicate a predominant activity within pulmonary tissue, with secondary involvement observed in the gastrointestinal tract. Specifically, Chonluten has been studied in preclinical research contexts involving: post-infectious pulmonary recovery states chronic cardiopulmonary functional impairment persistent respiratory dysfunction recovery phases following prolonged mechanical ventilation long-term pulmonary adaptation after remission of granulomatous conditions acute respiratory distress and hypoxia-associated states high physiological load and exercise-related respiratory stress maintenance of respiratory function in ageing biological systems inflammation-driven pulmonary mucosal dysregulation inflammatory states and alterations of the gastrointestinal mucosa

CJC-1295 is a synthetic analogue of growth hormone–releasing hormone (GHRH) investigated in preclinical research for its involvement in growth hormone– and insulin-like growth factor 1 (IGF-1)–associated signaling pathways. Experimental studies have examined how incorporation of a Drug Affinity Complex (DAC) may extend the peptide’s plasma persistence, allowing prolonged observation of GH–IGF axis dynamics under controlled laboratory conditions. In preclinical experimental settings, CJC-1295 has been explored in relation to: – protein synthesis–associated anabolic signaling– lipid metabolism and body composition–related biochemical pathways

Modified GRF is a truncated peptide analogue of growth hormone–releasing hormone (GHRH) investigated in preclinical research for its involvement in GHRH-mediated signaling pathways. In experimental settings, Modified GRF has been explored in relation to: – muscle repair– and growth-associated cellular signaling – wound-associated tissue remodeling processes – bone metabolism and structural signaling pathways – lipid metabolism and fat-oxidation–related biochemical pathways – metabolic regulation–associated signaling networks – glucose homeostasis– and immune-related regulatory pathways

Colivelin is a humanin-family peptide that has been extensively investigated in preclinical research models for its involvement in neuronal stress-response pathways. Experimental studies conducted in vitro and in vivo indicate that Colivelin may influence mechanisms associated with amyloid-related aggregation processes, neuronal apoptosis, and synaptic plasticity regulation under neurodegenerative conditions.   

Cortagen has been investigated in preclinical and exploratory research settings for its potential involvement in brain reparative processes, cerebroprotective responses, and nootropic-like activity, within experimental models of cerebral stress and degeneration. Research literature has explored Cortagen in relation to the following neurobiological contexts: Cerebral lesion and injury models Neurodegenerative and dementing process models, including protein-aggregation and vascular-associated degeneration Extrapyramidal and movement-disorder research models Spinal and cerebellar system dysfunction models Central nervous system involvement in immune-mediated and inflammatory conditions Motor impairment and hemiplegia-related models Paralytic and neuromuscular dysfunction models Cerebral involvement in bacterial meningeal inflammation models Hemorrhagic cerebral stress models Transient and persistent cerebral ischemia models 

DNSP-11 is a short amidated peptide derived from the proGDNF domain that has been investigated in preclinical research models for its neurotrophic-like activity within dopaminergic systems. Experimental studies conducted in vitro and in vivo suggest that DNSP-11 may support dopaminergic neuron resilience, neuroadaptive responses, and neuronal survival mechanisms under conditions of neurodegenerative stress.DNSP-11 has been explored in research contexts related to:Dopaminergic neuron degeneration modelsNigrostriatal system dysfunctionNeuroprotective and neurorestorative pathwaysModulation of dopamine and dopamine metabolite levelsMotor asymmetry and behavioral outcome modelsNeuronal survival and anti-apoptotic signalingNeurite outgrowth and neuronal differentiationToxin-induced neurodegeneration models

Delta sleep-inducing peptide (DSIP) is a neuropeptide that has been investigated in experimental and preclinical research settings for its involvement in the regulation of multiple endocrine and physiological processes, particularly those related to sleep–wake modulation and adaptive stress responses. Experimental studies suggest that DSIP may be associated with: Modulation of sleep-related physiological processes Regulation of sleep quality under conditions of chronic sleep disruption Adaptive responses to physiological and psychological stress Influence on autonomic and cardiovascular regulatory parameters Modulation of pain-related sensory processing

Epitalon stimulates the renewal of the whole body, beginning with the inside organs and working its way outward to the skin. It demonstrates a variety of bioactivities, including the following: Improving ocular retina condition in retinitis pigmentosa Anti-aging by activating chromatin in old age Anticancer and antitumour metastatic effects Activation telomerase Elongation of telomeres Survival of cells, resistance to stress and oxidative changes Balancing of endocrine secretion, improvement pineal gland function and increases the release of melatonin Decreased cortisol levels Increased antioxidant enzymes Increased brain health  

FGL has been investigated in experimental and preclinical research settings for its role in supporting synapse formation between neurons, a process associated with synaptic plasticity and structural neuronal adaptation. Increased activity-dependent synaptic communication observed in research models suggests that FGL may contribute to information encoding mechanisms underlying learning and memory-related processes. According to experimental studies, FGL has been explored in relation to the following neurobiological contexts: Neuroprotective mechanisms in neuronal stress models Modulation of cognitive performance parameters in experimental systems Neural recovery and adaptation following traumatic brain injury models Protection against experimentally induced neurotoxic stress Memory-related processes in learning paradigms Learning-associated synaptic plasticity mechanisms Neurodegenerative and cognitive decline research models Modulation of neuroinflammatory signaling in central nervous system models Regulation of mood-related behavioral parameters in experimental settings Activity-dependent enhancement of excitatory synaptic transmission      

Follistatin-344 is a synthetic analogue of the naturally occurring follistatin protein. In preclinical and experimental research, it has been investigated for its interactions with signaling pathways involving myostatin, activins, and follicle-stimulating hormone (FSH). Findings from in vitro and animal studies suggest that modulation of these pathways may be associated with changes in cellular differentiation processes, tissue remodeling dynamics, and selected regulatory signaling mechanisms. These observations position Follistatin-344 as a molecule of interest in research contexts focused on tissue biology, regenerative signaling, and growth-regulatory pathways.

FOXO4-DRI is a research peptide investigated for its ability to selectively interact with cellular pathways associated with senescence. Preclinical studies suggest that modulation of senescent cell populations may support improvements in biological function and tissue-level homeostasis in experimental models of aging.  According to experimental and preclinical research observations, FOXO4-DRI has been associated with the following effects: Selective induction of apoptosis in senescent cells in laboratory models Improvement of physical performance parameters in aging animal studies Support of tissue and organ function markers in preclinical research Contribution to the restoration of tissue homeostasis under experimental conditions      

GcMAF Frag (Gc protein–derived macrophage activating factor fragment) is a peptide fragment derived from vitamin D–binding protein (DBP) and studied for its interaction with macrophages, key cells of the innate immune system involved in immune surveillance and phagocytic processes. In experimental and preclinical research settings, GcMAF Frag has been investigated for its ability to influence macrophage-associated signaling pathways and immune-related functional markers. Within controlled laboratory models, exposure to GcMAF-related fragments has been associated with modulation of macrophage activity, including phagocytosis-related assays and cytokine-associated readouts. For this reason, the peptide is primarily used as a research tool in studies focused on immune regulation, inflammatory signaling, and host defense mechanisms. Chemical modifications such as N-terminal acetylation and C-terminal amidation have been evaluated in peptide research for their impact on structural stability and resistance to enzymatic degradation. In experimental systems, these features may contribute to enhanced molecular stability, prolonged functional persistence, and optimized receptor interaction profiles under in vitro conditions.

GDF11 has been shown to improve the outcomes of neurodegenerative and neurovascular diseases, increase the amount of skeletal muscle and boost muscular strength. It also has the power to reverse age-related degenerative alterations, as well as govern organ and skin regeneration following damage. These are all examples of its biological effects, which include reversing senescence.

GDF-8 is involved in the regulation of myostatin activity, a key biological factor that normally limits muscle growth and regeneration. Experimental and preclinical research indicates that modulation of this pathway influences muscle and tissue dynamics associated with repair and adaptation. According to research-based observations, GDF-8 has been associated with the following effects: Enhancement of muscular regeneration and recovery processes following injury Support of the body’s regenerative capacity at the tissue level Increase in myofiber hypertrophy in experimental models

GHK is a naturally occurring tripeptide that has been widely investigated in experimental and laboratory research for its involvement in multiple biological processes. Scientific studies suggest that GHK is associated with the following research-observed activities: Support of tissue repair processes: Linked to collagen-related pathways and cellular mechanisms involved in wound repair and tissue maintenance. Modulation of fibrinogen-related pathways: Associated with inflammatory signaling regulation and vascular biology mechanisms in experimental models. Activation of DNA repair–related gene networks: Observed to influence pathways connected to genomic stability and cellular maintenance. Engagement of the ubiquitin/proteasome system: Studied for its role in supporting protein quality control and cellular homeostasis. Influence on insulin and insulin-like signaling pathways: Associated with metabolic regulation mechanisms in gene expression studies. Collectively, these properties make GHK a molecule of interest in research areas such as cardiovascular biology, aging mechanisms, metabolic regulation, and tissue regeneration. 

GHK-Cu is a naturally occurring copper-binding tripeptide widely studied for its role in tissue maintenance, cellular repair, and gene-regulatory processes. Research has associated GHK-Cu with multiple biological activities relevant to skin biology, cellular regeneration, and protective mechanisms at the molecular level. According to experimental and research observations, GHK-Cu has been associated with the following effects: Improves skin density and firmness Reduces the appearance of fine lines and deeper wrinkles Helps counteract photodamage related to environmental exposure Supports biological processes linked to hair follicle activity Demonstrates gene-regulatory activity relevant to cancer research models Supports mechanisms involved in nerve regeneration Activates pathways associated with DNA repair and cellular recovery All listed effects are derived from laboratory, preclinical, or controlled research contexts and are presented for scientific and educational purposes only.

GHRP-2 is a synthetic hexapeptide classified as a growth hormone secretagogue and a selective agonist of the ghrelin receptor (GHS-R1a). It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and pituitary-associated communication processes. Due to its targeted receptor activity, GHRP-2 remains a compound of interest in experimental models investigating signaling mechanisms related to growth hormone regulatory pathways and systemic endocrine coordination.

GHRP-6 is a synthetic hexapeptide classified as a growth hormone secretagogue and a selective agonist of the ghrelin receptor (GHS-R1a). It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and neuroendocrine communication processes. Due to its well-characterized receptor activity, GHRP-6 remains a compound of interest in experimental models investigating ghrelin-related signaling and growth hormone regulatory pathways.

HCG is a glycoprotein hormone studied in research contexts for its role in gonadotropin-related signaling pathways and endocrine regulatory mechanisms. It is associated with receptor-mediated processes involved in hormonal communication and system-wide endocrine coordination. Due to its well-characterized structure and role in endocrine signaling, HCG remains a key compound in experimental models investigating regulatory pathways of the hypothalamic–pituitary–gonadal axis.

HGH (191 AA) is a recombinant peptide hormone studied in research contexts for its role in endocrine signaling and systemic physiological regulation. It is associated with complex signaling pathways involved in cellular communication, metabolic coordination, and tissue-level regulatory processes. Due to its broad receptor distribution and multi-system activity, HGH remains a key subject of investigation in experimental models exploring integrative endocrine and metabolic mechanisms.  

HGH Fragment (176–191) is a synthetic peptide derived from the C-terminal region of human growth hormone. It is studied in research contexts for its selective interaction with signaling pathways associated with lipid metabolism and energy regulation. Unlike full-length HGH, this fragment demonstrates a more targeted activity profile, making it a subject of investigation in experimental models focused on metabolic signaling and pathway-specific regulatory mechanisms.

Humanin is a 24–amino acid mitochondrial-derived peptide in which each residue contributes to its biological activity. A key residue is serine at position 14, which is associated with neuroprotective properties. Substitution of this amino acid with glycine results in a more potent variant known as Humanin-G (HNG). Experimental research indicates that HNG exhibits substantially enhanced biological activity compared to native Humanin and is particularly effective in preserving mitochondrial function and cellular integrity under stress conditions. In preclinical and laboratory research settings, Humanin-G has been shown to support cellular survival by limiting mitochondrial dysfunction and reducing pathways associated with programmed cell death. These properties have generated scientific interest in its role within research models of ischemic injury, neurodegenerative processes such as Alzheimer’s disease, and other conditions linked to cellular stress. Based on experimental observations, Humanin-G has been associated with:  Protection against mitochondrial dysfunction in stressed cells Reduction of apoptosis-related cellular pathways Support of cellular longevity mechanisms in research models Modulation of insulin sensitivity in experimental systems Neuroprotective effects observed in models of ischemia and neurodegeneration

IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1, designed to exhibit modified binding characteristics and extended activity in research environments. It is studied for its interaction with cellular signaling pathways involved in growth factor regulation, intercellular communication, and system-wide biological coordination. Due to its structural modifications and prolonged activity profile, IGF-1 LR3 remains a key compound in experimental models investigating complex signaling dynamics and regulatory mechanisms at the cellular level.

Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue and a ghrelin receptor (GHS-R1a) agonist. It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and pituitary-associated communication processes. Due to its selective receptor activity profile, ipamorelin remains a compound of interest in experimental models investigating growth hormone–related signaling and neuroendocrine regulatory mechanisms.

Research and experimental studies indicate that KCF-18 is associated with the following characteristics and biological activities: Interaction with multiple pro-inflammatory cytokine pathways, including TNF-α, IL-1β, and IL-6 Functioning as a cytokine-binding decoy in experimental models Modulation of inflammatory signaling involved in vascular and endothelial processes Influence on immune cell adhesion and transmigration in laboratory settings Potential role in the regulation of immune response signaling Structural design that supports interaction with multiple cytokine-related targets

Kisspeptin is a naturally occurring peptide in humans that has been extensively studied for its role in hormonal signaling associated with puberty and reproductive function. In research settings, it has also been linked to regulatory processes involving renal function, angiogenesis, testosterone modulation, and mood- and behavior-related neural pathways. The peptide has been identified in the brain and has been investigated for its association with mechanisms that limit tumor development and metastatic progression in experimental models. Of particular scientific interest is kisspeptin’s ability to influence gonadotropin-releasing hormone (GnRH) signaling, positioning it as a key regulator within the neuroendocrine system. Additional research suggests that kisspeptin may be involved in biological processes relevant to aging and age-associated functional changes.

KPV is a short peptide that has been extensively investigated in experimental models for its role in the modulation of inflammatory responses. Current research has focused primarily on its involvement in studies related to inflammatory bowel disease. Additional studies in wound-healing models suggest that KPV, along with other α-MSH–derived peptides, may influence tissue repair processes, inflammatory regulation, microbial control, and structural outcomes associated with healing. According to experimental and preclinical research, KPV has been studied in relation to: Inflammatory mechanisms associated with acne and cystic acne Intestinal inflammatory signaling in Crohn’s disease research models Experimental models of ulcerative colitis and irritable bowel syndrome Inflammatory skin conditions such as eczema and psoriasis Immune and inflammatory responses explored in mold- and Lyme-related models Neuroinflammatory pathways investigated in multiple sclerosis research Inflammatory conditions affecting skin and ocular tissues Airway inflammation examined in allergic asthma models Joint inflammation studied in arthritis-related research

L-Glutathione is a naturally occurring tripeptide that has been extensively studied for its central role in cellular protection and metabolic balance. Research and experimental data indicate that L-Glutathione is associated with the following biological processes: Regulation of intracellular redox balance and antioxidant defenses Protection of cells from oxidative stress and reactive oxygen species Support of detoxification and cellular clearance pathways Modulation of immune and inflammatory signaling mechanisms Maintenance of mitochondrial function and cellular energy metabolism Preservation of protein structure and prevention of oxidative damage Involvement in cellular stress adaptation and aging-related processes

Livagen is a short bioregulatory peptide that has been investigated in experimental research for its influence on DNA organization and gene expression. It is primarily recognized for its association with chromatin decondensation, a process that increases DNA accessibility and has been linked to cellular profiles typically observed in younger cells. Scientific research has focused predominantly on immune system lymphocytes, where Livagen has been shown to modulate gene activity and cellular function. Through these mechanisms, Livagen has been studied for its involvement in biological processes related to immune regulation and signaling pathways associated with cardiovascular, gastrointestinal, neurological, and immune system function. Experimental findings have also explored Livagen’s role in nociception and pain-related signaling. Ongoing research continues to examine Livagen’s broader relevance in studies of aging, cellular senescence, and long-term biological regulation.

LL-37 is the only known human member of the cathelicidin family, a broad class of proteins commonly referred to as antimicrobial peptides (AMPs). These peptides are primarily expressed in macrophages and polymorphonuclear leukocytes, where they contribute to innate immune defense against microbial threats. Beyond their antimicrobial role, experimental research has demonstrated that LL-37 is involved in a wide range of biological processes related to immune regulation, inflammation, tissue repair, and cellular signaling. For this reason, LL-37 has been extensively studied in research models relevant to cancer biology, autoimmune mechanisms, inflammatory conditions, and wound-related processes. According to experimental research, LL-37 has been investigated in relation to: Inflammatory processes associated with rheumatoid arthritis Immune dysregulation studied in lupus models Chronic and acute inflammatory conditions Vascular inflammation relevant to atherosclerosis research Skin inflammation examined in psoriasis models Intestinal inflammation studied in colitis research Gastrointestinal inflammatory signaling in Crohn’s disease models Tissue injury and repair processes associated with ulcers Impaired wound-healing environments such as diabetic foot models Cellular and immune mechanisms explored in cancer research Broad antimicrobial activity within innate immune defense systems

Melanotan 1 is a synthetic peptide originally developed as an analog of alpha-melanocyte-stimulating hormone (α-MSH) to study sunless pigmentation mechanisms. Subsequent experimental and preclinical research has shown that Melanotan 1 interacts with multiple melanocortin pathways, resulting in a range of physiological effects beyond skin pigmentation. These include modulation of signaling pathways involved in cardiovascular regulation, appetite and energy balance, and central nervous system function. Ongoing research continues to explore the broader biological roles of Melanotan 1 across multiple physiological systems.

Experimental and preclinical studies suggest that Melanotan-2 is associated with several biological effects mediated through the melanocortin receptor system, including: Regulation of skin pigmentation processes related to tanning Modulation of neurobehavioral pathways linked to sexual arousal Influence on appetite control and satiety signaling Interaction with neural mechanisms involved in compulsive behavior Modulation of metabolic pathways related to glucagon signaling Effects explored in research models relevant to autism-associated traits Influence on reward and reinforcement pathways studied in addiction research

MIF-1 (Melanocyte-Inhibiting Factor 1) has been investigated for its role in central nervous system signaling and neuronal regulation. Scientific studies have examined MIF-1 in relation to multiple biological processes associated with brain function, neurochemical balance, and cellular resilience. Research has primarily focused on MIF-1 in the context of the following areas: Neurotransmitter Modulation: Associated with the regulation of dopamine and serotonin signaling pathways involved in motor function and mood-related processes. Neuroplasticity: Linked to mechanisms that support synaptic plasticity relevant to learning and memory in experimental research. Neuroprotective Activity: Studied for its involvement in cellular pathways that help protect neurons from oxidative and inflammatory stress. Neuroregenerative Processes: Investigated for its role in mechanisms related to neuronal repair and cellular renewal in research models of neural injury. Mood-Related Signaling: Explored for its influence on neurochemical pathways associated with emotional regulation and stress responses. Cognitive Function: Associated in experimental settings with processes relevant to memory, attention, and higher-order cognitive performance. Neurodegenerative Research: Examined in studies focused on biological pathways involved in neurodegenerative conditions and age-related neural changes.

MOTS-c is a mitochondria-derived peptide that has been widely investigated in experimental and preclinical research for its role in metabolic regulation and cellular energy balance. Scientific studies have examined MOTS-c in relation to biological pathways associated with physical performance, metabolic homeostasis, age-related processes, and systemic cellular signaling. Research has primarily focused on MOTS-c in the context of the following areas: Muscle Metabolism: Studied for its association with glucose utilization, energy handling, and metabolic adaptation in skeletal muscle. Fat Metabolism: Investigated for its involvement in adipose tissue regulation, lipid utilization, and pathways related to energy expenditure. Insulin Sensitivity: Examined in research models addressing early metabolic changes and glucose regulation mechanisms. Bone Metabolism (Osteoporosis Research): Explored for its role in pathways related to osteoblast activity, collagen production, and bone integrity. Longevity Research: Studied in relation to mitochondrial signaling, aging-associated pathways, and lifespan-related genetic variants. Heart Health: Investigated for its association with endothelial function, vascular signaling, and cardiovascular stress responses.

N-Acetyl Epitalon Amidate is a synthetically modified derivative of Epitalon (epithalamin), obtained through N-acetylation and C-terminal amidation. The acetylation and amidation modifications applied to N-acetyl Epitalon Amidate have been studied for their ability to confer enhanced molecular stability, extended half-life, and improved receptor interaction compared to the unmodified peptide. Epitalon and its modified forms have been extensively studied in relation to cellular aging processes, telomere biology, circadian regulation, and genomic stability. In particular, research has examined this peptide in the context of the following biological areas: Telomerase-related pathways Cellular stress resistance Endocrine and circadian regulation Stress hormone modulation Antioxidant activity Central nervous system function Longevity-related processes Note: Due to N-acetylation and amidation, the peptide exhibits reduced polarity, which may result in lower water solubility compared to unmodified Epitalon.

N-Acetyl Selank Amidate is a synthetically modified peptide that has been widely studied in experimental research for its role in neurogenic, neuroregulatory, and neurorestorative biological processes. Scientific investigations have primarily focused on its interaction with central nervous system signaling, neurochemical balance, immune-related modulation, and stress-associated pathways. Research has examined N-Acetyl Selank Amidate in relation to the following biological areas: Regulation of emotional and stress-related signaling Cognitive functions related to memory formation, information processing, and recall Modulation of attention, focus, and mental fatigue Learning-related mechanisms and adaptive cognitive responses Higher-order cortical functions, including speech, reasoning, and motor coordination Support of overall neurophysiological balance Immune-related signaling and immune system modulation Neurochemical pathways explored in alcohol withdrawal research models Regulation of monoamine neurotransmitters and serotonin metabolism Increased expression of brain-derived neurotrophic factor (BDNF) in experimental settings Modulation of T-helper cell cytokine balance and interleukin-6 (IL-6) expression Activation of interferon-related signaling pathways involved in antiviral defense

N-Acetyl Semax Amidate is a synthetic peptide that has been widely investigated in experimental research for its involvement in neurogenic and neurorestorative biological processes. Scientific studies have explored its activity in relation to central nervous system signaling, cognitive performance, vascular-associated mechanisms, and immune-related pathways. Research has primarily examined N-Acetyl Semax Amidate in the context of the following biological effects: Neuroprotective pathways associated with neuronal resilience Mechanisms involved in limiting nerve damage and supporting neural integrity Cognitive functions related to memory, learning, and information processing Cardiovascular-related signaling studied in ischemic and hypoxic research models Neurobehavioral pathways relevant to attention regulation Modulation of attention and focus-related neural activity Stress- and pain-associated signaling pathways explored in experimental settings

NAD⁺ (Nicotinamide Adenine Dinucleotide) is a central cellular coenzyme essential for mitochondrial energy production and redox balance. It plays a critical role in oxidative phosphorylation, ATP synthesis, and metabolic regulation. NAD⁺ also functions as a substrate for sirtuins and PARP enzymes, contributing to DNA repair, cellular stress resistance, and longevity-associated pathways. Due to its involvement in bioenergetics and cellular resilience, NAD⁺ is widely studied in mitochondrial function, metabolic regulation, and age-related biological processes

Orexin-A is a neuropeptide that has been extensively studied for its role in the regulation of wakefulness and arousal. Research has also explored its involvement in pathways related to appetite regulation, locomotor activity, and autonomic nervous system signaling, including modulation of sympathetic tone. These findings highlight the importance of Orexin-A in maintaining physiological balance across sleep–wake cycles and energy-related processes.

Research indicates that Orexin-B is a neuropeptide involved in the regulation of wakefulness and arousal. It has been studied for its role in appetite-related signaling, locomotor activity, and modulation of sympathetic nervous system tone. Through its interactions with orexin receptors, Orexin-B contributes to neural pathways associated with vigilance, energy balance, and autonomic regulation.

Ovagen is a bioregulatory peptide that has been studied for its role in supporting gastrointestinal mucosal integrity and maintaining normal liver tissue structure. Research suggests it may help protect the gastrointestinal mucosal layer from stressors such as antibiotics, toxins, and anti-inflammatory agents, while also being associated with reduced fibrotic processes in liver tissue. Ongoing experimental studies are further evaluating Ovagen’s interaction with mechanisms involved in HIV viral replication.

Oxytocin is a multifunctional peptide hormone and neuropeptide involved in a wide range of physiological and psychological processes. Synthesized in the hypothalamus and released by the posterior pituitary gland, it acts both peripherally and within the central nervous system. Research has associated oxytocin with the following effects:Exhibits anti-inflammatory properties that support wound healing and tissue regenerationEnhances trust, empathy, and social recognition involved in interpersonal bondingImproves recognition of emotional expressions, supporting effective social communicationModulates neurotransmitter systems such as dopamine and serotonin, contributing to mood balance and stress reductionHas been investigated for potential roles in reducing symptoms associated with anxiety and depressive statesContributes to sexual receptivity and reproductive behaviors in both men and womenReduces activity of the amygdala, which is associated with fear and anxiety responsesInduces uterine contractions during labor and mediates milk ejection during breastfeeding

Research indicates that P21 is associated with increased levels of brain-derived neurotrophic factor (BDNF), a key molecule involved in neuronal development and synaptic plasticity. BDNF is linked to enhanced neurogenesis and has been shown in experimental models to modulate biological pathways related to amyloid plaque and tau protein formation, both of which are characteristic features of Alzheimer’s disease pathology. In addition, multiple studies suggest that P21 supports learning processes and cognitive performance by promoting neuroplastic mechanisms and maintaining synaptic function in the central nervous system.

PE-22-28 is a synthetic derivative of the naturally occurring peptide spadin that targets the TREK-1 channel. Since TREK-1 is found in brain regions that govern mood, memory, and learning, PE-22-28 was designed with the goal of being a potential treatment candidate for depression and a powerful stimulator of neurogenesis and synaptogenesis in the hippocampus. PE-22-28 is currently being researched for several applications, including: Antidepressant activity Enhancement of memory and learning Support for stroke recovery Potential roles in addressing neurodegenerative diseases such as Alzheimer’s Promotion of neurogenesis

Pegylated Mechano Growth Factor (PEG-MGF) is a modified splice variant related to insulin-like growth factor-1    (IGF-1). In experimental research settings, PEG-MGF has been studied for its role in supporting myoblast division and facilitating the fusion and maturation of muscle fibers. Pegylation enhances the peptide’s stability and circulating half-life, allowing prolonged biological activity compared to non-pegylated MGF. Based on preclinical and experimental studies, PEG-MGF has been investigated in relation to the following biological processes: Support of muscle tissue remodeling Stimulation of new muscle cell formation Neuroprotective mechanisms in experimental models Cardioprotective pathways associated with cellular survival Processes involved in wound healing and tissue regeneration Bone repair and osteogenic activity in injury models Regulation of body fat metabolism and lipid-related markers Modulation of immune-related cellular responses

Most peptides exert their biological effects by interacting with cell surface or intracellular receptors. However, a limited number of peptides are capable of binding directly to DNA, thereby influencing fundamental biological processes at the level of gene regulation. Pinealon is one of these bioregulatory peptides. It has demonstrated neuroprotective properties and is considered a promising candidate for research focused on the modulation and management of various neurological conditions. Pinealon is known to affect the central nervous system by influencing behavior while also protecting neurons and other cell types from oxidative damage. One of the most notable characteristics of Pinealon is its ability to cross the cellular membrane, nuclear membrane, and the blood–brain barrier. This unique property helps explain its capacity to interact directly with DNA and regulate gene expression. Pinealon has been associated in research with potential applications including: Anti-aging effects Neuronal protection Modulation of depressive pathways Research into neurological disorders such as Alzheimer’s disease and Parkinson’s disease Memory enhancement Regulation of sleep and circadian rhythms

PNC-27 is a synthetic research peptide studied for its selective activity against malignant cells. It is designed to bind to HDM-2, a protein that is abnormally expressed on the membranes of many cancer cells and is known to interact with the p53 tumor suppressor pathway. Experimental research indicates that PNC-27 can selectively induce cancer cell death by disrupting the integrity of the cancer cell membrane through a process known as membranolysis, while showing minimal interaction with non-cancerous cells.

PNC-28 is a synthetic peptide derived from the p53 protein, specifically from its MDM2-binding domain, and engineered with a penetratin sequence to enable efficient cellular uptake. It is studied for its ability to interact with dysregulated cellular pathways commonly found in transformed cells, particularly involving the MDM2 regulatory system. In experimental models, PNC-28 has been associated with the induction of non-apoptotic cell death mechanisms, characterized by loss of membrane integrity rather than classical programmed cell death. This feature makes it of particular interest in research settings where resistance to apoptosis is observed. Due to its unique mechanism and intracellular activity, PNC-28 is primarily used as a research tool in studies related to tumor biology, cellular stress responses, and alternative cell death pathways.